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E-mail address: louis@imbb.forth.gr (C. Louis).We are developing a set of ontologies dealing with vector-borne diseases as well as the arthropod vectors
that transmit them. After building ontologies for mosquito and tick anatomy we continued this project
with an ontology of insecticide resistance followed by a series of ontologies that describe malaria as well
as physiological processes of mosquitoes that are relevant to, and involved in, disease transmission. These
will later be expanded to encompass other vector-borne diseases as well as non-mosquito vectors. The
aim of the whole undertaking, which is worked out in the frame of the international IDO (Infectious Dis-
ease Ontology) project, is to provide the community with a set of ontological tools that can be used both
in the development of speciﬁc databases and, most importantly, in the construction of decision support
systems (DSS) to control these diseases.
 2010 Elsevier Inc. All rights reserved.1. The problem of vector-borne diseases
Epidemiologists have brought together in one ‘‘functional‘‘
group a series of diseases of different aetiology and pathogenesis
that share one key component: their mode of transmission (see
[1] and several chapters of [2] for speciﬁc questions addressing in-
sect-borne diseases and their vectors). These diseases are transmit-
ted by the bite of a speciﬁc arthropod vector, which is usually (but
not exclusively) an insect. The pathogenic agent is usually passed
with the saliva transferred during the bite to the potential patient.
Two additional characteristics are shared by most vector-borne
diseases, namely most people affected live in the tropical regions
of the world and, connected to this, the diseases affect mostly pop-
ulations that are also heavily affected by poverty. The pathogens
responsible for these diseases are very diverse, ranging from proto-
zoan parasites (e.g. Plasmodium spp. in malaria, Leishmania spp. in
leishmaniosis) and bacteria (e.g. Borrelia spp. in Lyme disease), to
worms (e.g. Nematodes in lymphatic ﬁlariasis and river blindness)
and viruses (e.g. Dengue, Yellow fever). Similarly, the vectors that
transmit them are also very diverse and range from mosquitoes
(e.g. malaria and Dengue) and ﬂies (e.g. Tsetse in African trypano-
somiasis) to kissing bugs (Chagas’ disease) and ticks (e.g. Lyme dis-ll rights reserved.
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diseases along with the corresponding aetiologic agents and
arthropod vectors. The great variation in the biology of both patho-
gens and vectors, and the ensuing differences in the illnesses
caused, makes it impossible to address vector-borne diseases as a
cohesive clinical entity. Importantly, these difﬁculties also affect
signiﬁcant aspects such as prevention, epidemiology, therapy, etc.
A common theme, which in a sense unites these diseases, is the
fact that their transmission can be blocked if the agents that trans-
mit them, i.e. the arthropod vectors, are removed from the perti-
nent chain of events [3]. Vector control has therefore historically
become a conditio sine qua non for the control of these infections
[4,5], and this fact has been exempliﬁed by the elimination of ma-
laria from most non-tropical areas of the globe [6]. While leading
to about half a billion cases in the tropics and still being responsi-
ble for anything between one and three million deaths (mostly
children in sub-Saharan Africa) every year, this killer illness has
practically disappeared from Europe and North America through
intense insecticidal measures aimed at eliminating the anopheline
vectors [6]. It should be stressed here that, with the exception of
the Yellow fever [7], no vaccine is currently available for any
vector-borne disease as an alternative prevention strategy that
would act on a different level than that of the actual vector.
Prevention focused on the vector includes not only control of insect
populations through environmental management or the use of
chemicals, but also the protection of individuals through the use
of clothing, repellents, nets and screens [8]. In addition, prevention
Table 1
Some important vector-borne diseases, their pathogens and their arthropod vectors; commonly used synonyms are also listed.
Disease Pathogen Vector(s)
(i) Bacterial diseases
Louse-borne relapsing fever Borrelia recurrentis Louses
Lyme disease Borrelia burgdorferi Ticks
Plague Yersinia pestis Fleas
Tick-borne relapsing fever var. spirochetes Ticks
Tularemia Francisella tularensis Ticks, deer ﬂies
(ii) Viral diseases
Chikungunya fever Chikungunya virus Aedes aegypti, Ae. albopictus
Dengue fever DENV Ae. aegypti, Ae. albopictus
Eastern equine encephalitis EEEV Aedes spp., Coquillettidia spp.
Culex spp.
Japanese encephalitis JEV Culex tritaeniorhynchus
La Crosse encephalitis La Crosse virus Ae. triseriatus
Saint Louis encephalitis SLE Culex spp.
West Nile encephalitis WNV Culex spp.
Western Equine Encephalitis WEEV Various mosquito species
Yellow fever YFV Aedes spp., Haemagogous spp.
(iii) Parasitic diseases
African trypanosomiasis1 Trypanosoma brucei Glossina spp.2
American trypanosomiasis3 Trypanosoma cruzi triatominae4
Leishmaniasis Leishmania spp. Lutzomyia spp.5, Phlebotomus spp.5
Lymphatic ﬁlariasis6 Wuchereria bancrofti, Brugia malayi Various mosquito species
Malaria Plasmodium spp. Anopheles spp.
Onchocerciasis7 Onchocerca volvulus Simullium spp.8
Commonly used synonyms: 1Asian tiger mosquito, 2sleeping sickness, 3Tsetse, 4Chagas’ disease, 5kissing bugs, 6sand ﬂies, 7elephantiasis, 8river blindness, and 9black ﬂies.
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drugs that block infection in its very initial stages [9].
Although greatly successful in the previous century, insect-con-
trol programmes are now immensely obstructed by a variety of
factors. These range from community opposition to the widespread
use of chemicals [10], to the development of resistance against
these very chemicals by the insect vectors to be controlled [11].
Moreover, these problems are aggravated by several additional
facts: resistance against drugs is also encountered in the pathogens
[12]; vaccine development, if at all possible, is slow [13]; new drug
development is not only slow but extremely expensive and the
areas affected by the diseases in question are certainly not the ones
that can easily spearhead such efforts due to the lack of economic
and scientiﬁc resources in them [14]. All of the difﬁculties ad-
dressed above have led to a resurgence of vector-borne diseases,
which now pose again a threat to more than just the tropical re-
gions of the world [15]. It is therefore of utmost importance to de-
velop innovative strategies for the control of vector-borne diseases.
One novel approach is to use information technologies (IT) as a
complement to the application of modern biochemical/biological
techniques, often based on molecular biology, in the study of the
biology of disease vectors. While the latter approaches make use
of scientiﬁc research products such as whole genome sequences
[16,17], transgenesis [18], and the use of other ‘‘intelligent” ap-
proaches [19], the former can introduce new speciﬁc tools, such
as databases and DSS, that can be used for a more efﬁcient, and of-
ten close-to-the-ﬁeld management of pertinent disease data,
including entomological data.
In this context, several years ago our group embarked on a long
project that involves the development of ontologies dealing with
vector-borne diseases and their vectors [20,21]. The obvious ratio-
nale behind this is the potential of such ontologies to unify the
‘‘language” spoken by vector biologists, epidemiologists and other
specialists. It should be noted here that the usage of very speciﬁc
terms and, even worse, jargon often makes it more difﬁcult to ob-
tain a wide understanding of certain terms. For example, the terms
‘‘refractory to” or ‘‘resistant to”, combined with the words ‘‘ma-
laria” or ‘‘Plasmodium” or ‘‘infection” are all synonyms. We obvi-
ously do not see the need for ontologies restricted only to theactual vectors of the vector-borne diseases but also expanding into
the ‘‘area” of the diseases and, most importantly, the two have to
be interoperable. The ultimate end, thus, is to build a comprehen-
sive ontology for insect-borne diseases that may consist of sub-
ontologies, each addressing a speciﬁc aspect of the whole. In the
frame of the Infectious Disease Ontology project, IDO [22 and
http://www.infectiousdiseaseontology.org/Home.html], we initi-
ated this effort focusing on malaria, but we are already expanding
this to encompass most other vector-borne diseases as well. The
choice of developing the malaria ontology in close partnership
with the IDO project was made because of its speciﬁc advantages.
Having IDOMAL as an extension of such a reference ontology, as
opposed to an autonomous approach, allows for a superior interop-
erability of all individual application ontologies in the context of
the greater infectious disease domain. The ontologies that we are
working on, some of which are already available and some under
development, will be presented below in a summary form.2. Ontologies and vector-borne diseases: an ephemeral account
There are several aspects of vector-borne diseases that are in
need of ontological description; they range from those that deal
with the diseases as such (e.g. pathogenesis, clinical aspects, ther-
apy, etc.), to vector biology (physiological processes of the vectors)
and to epidemiology and control in the widest sense of the terms
(prevention, insect control, etc.). As stated earlier, these aspects
are extremely diverse and complex, simply given the multitude
of organisms involved (vectors and pathogens in addition to the
human host) and the fact that we are often dealing with popula-
tions, rather than individuals (additional level of granularity!).
The construction of a comprehensive ontology, thus, if at all feasi-
ble, must be addressed using a piecemeal approach. It is clear that
certain fundamental decisions have to be taken at the initial
phases, and an open-ended advance is, in our mind, a must. We
therefore decided, early on, that the end product (i) would have
to follow the rules set by the OBO Foundry [23] and, if no other rea-
sons dictated a different decision, (ii) should be based on BFO, the
basic formal ontology [24,25]. The reasoning behind the decision
Table 2
The table shows the comparison between the non-BFO compliant MIRO and the
corresponding term(s) after introduction into IDOMAL and adherence to BFO.
MIRO IDOMAL
DEF is_a synergist DEF has_role insecticide synergist
Synergist is_a insecticidal substance DEF is_a chemical compound
Chemical compound is_a abiotic object
Abiotic object is_a object
Insecticide synergist is_a role
Table 3
The table shows a small part of the physiological processes of vectors, described in
IDOMAL, that has extensive overlap with the GO-Biological Process sub-ontology (GO
IDs are indicated in parentheses). All terms are connected with terms lying above and
to the left of them with is_a relations. (‘‘IDOMAL:XXXXXXX, no GO term in BP”) refers
to terms for which no corresponding term is found in the Biological Process sub-
ontology. For three cases similar terms, indicated at the bottom part of the table, are
found in the sub-ontology of molecular function.
Metabolic process (GO:0008152)
Catabolic process (GO:0009056)
Carbohydrate catabolism (GO:0016052)
Glycolysis (GO:0006096)
Cleavage by carbohydrases (IDOMAL:0001299, no GO term in BP)
Lipid catabolic process (GO:0016042)
Fatty acid b-oxidation (GO:0006635)
Cleavage by esterases (IDOMAL:0001298, no GO term in BP)a
Protein catabolic process (GO:0030163)
Cleavage by peptidases (IDOMAL:0001300, no GO term in BP)b
Cleavage by serine proteases (IDOMAL:0001297, no GO term in BP)c
Pigment metabolic process (GO:0042440)
GO terms describing molecular function.
a GO:0016788 (hydrolase activity, acting on ester bonds).
b GO:0008233 (peptidase activity).
c GO:0008236 (serine-type peptidase activity).
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tools is to be achieved, these two choices are a prerequisite. We
considered this choice, though, to be of more relevance to the ﬁnal
goal and we therefore decided to keep a certain degree of ﬂexibility
throughout the project until a uniﬁed vector-borne disease ontol-
ogy is fully developed. One example for such a ﬂexible approach
is the fact that the ontology of insecticide resistance in mosquitoes,
MIRO [26], which we constructed, does not comply with the BFO in
its initial versions; rather, it is structured such that it can be
adopted, without many problems, by the community that immedi-
ately needs to apply it in the ﬁeld (see below). The MIRO forms the
core of the related database on insecticide resistance (IRbase;
http://anobase.vectorbase.org/ir/) that we also developed [26],
and which was adopted for immediate use by the Regional Ofﬁce
for Africa of the World Health Organization (WHO-AFRO): all ﬁeld
studies that are run under direct or indirect support by WHO-AFRO
are asked to submit their data to IRbase. Furthermore, it is planned
to move the curation of both database and ontology to an African
country with the support of WHO-AFRO. As we have not aban-
doned the goal of ultimately unifying all ontologies we currently
construct, we are in the process of restructuring the MIRO along
BFO standards, such that its contents can be later directly imported
and incorporated into the comprehensive ontology on vector-
borne diseases. At the same time, this will also add accuracy to
the ontology (see below). A similar restructuring after the ﬁrst ver-
sion was made publicly available occurred with the TGMA, the
ontology of the mosquito gross anatomy [20]; we decided for the
reasons outlined above, that we should conform the TGMA to the
CARO, the Common Anatomy Reference Ontology [27], which is
BFO-based. The ﬁrst version was, thus, retracted and a CARO-com-
pliant TGMA version was then submitted to the OBO Foundry and
is now available (http://www.obofoundry.org/cgi-bin/detail.cgi?id
=mosquito_anatomy). In contrast to TGMA, TADS, the tick anatomy
ontology that we constructed next [20, http://www.obofoun-
dry.org/cgi-bin/detail.cgi?id=tick_anatomy], was directly built as
an extension to CARO.
TheMIRO has also been already submitted to, and is listed by the
OBO Foundry (http://www.obofoundry.org/cgi-bin/detail.cgi?
id=mosquito_insecticide_resistance). It consists of four sub-ontolo-
gies that cover all aspects of insecticide resistance of mosquito dis-
ease vectors, with a special emphasis on ﬁeldwork and monitoring.
Thus, although geneticmechanisms of resistance are covered, this is
not done in detail, since many of those are processes already cov-
ered by the Gene Ontology [28,29]. Furthermore, the MIRO’s ﬁfth
major component, a geographical one, uses in toto the controlled
vocabulary Gazeteer (http://darwin.nerc-oxford.ac.uk/gc_wiki/in-
dex.php/GAZ_Project) in order to provide IRbase curators with re-
cords describing the areas in which data were collected. The MIRO
is constantly being updated, upon request, bymembers of the inter-
national community that is involved in the study of insecticide
resistance. To help cover the wishes of the pertinent community,
we recruited the help of an expert on insecticide resistancewho also
co-authored the publication of the MIRO [26]. Moreover, all geo-
graphical locations reported to IRbase, which so far are spread over
5 continents, are annotated using the GAZ. Should a location not be
listed, it is communicated to the curators of the GAZ ontology to be
placed at the appropriate position. As mentioned earlier, the fact
that MIRO is not BFO compliant renders it easier to be understood
by non-experts, but at the same time it looses in accuracy. Table 2
illustrates this point. In MIRO, two steps are enough to deﬁne DEF
(S,S,S-tributyl phosphorotrithioate), to some extent wrongly, as an
insecticidal substance. In contrast, ﬁve steps are necessary in IDO-
MAL, but DEF is deﬁned much more accurately here. As is the case
with most, if not all biomedical ontologies, MIRO cannot be consid-
ered as complete. More insecticides are being developed, new
modes of action are discovered and, unfortunately, and spread ofinsecticide resistance simply cannot be stopped. MIRO is therefore
under steady curation and new versions are made public as soon
as the community requires pertinent changes.
Another, originally nameless, ontology that we build covers
physiological processes of mosquitoes that are involved in disease
transmission. Our original decision to make this an autonomous
ontology was later modiﬁed, and we are presently in the process
of fully incorporating it into IDOMAL (see below). The processes
listed do not only address the actual disease transmission, i.e. the
interplay between vectors and pathogens but, importantly, also
the actual progression of events in the vector. We want to stress
that the processes mentioned here are, in their vast majority, pro-
cesses on the level of the organism and not cellular or sub-cellular
ones, such as the ones covered by the GO [28,29]. Moreover, many
of these processes are species-speciﬁc, and therefore also excluded
from the GO, which is focused on processes of a general nature (but
see below). Thus, (near) top level classes are, among others, behav-
ior, sensory perception, processes of the immune system and
nutrition, all physiological components that directly affect the
transmission potential of disease vectors. As an example, when
looking at the children terms of ‘‘behavior”, one will ﬁnd a line of
terms leading through the adult feeding behavior, to entities such
as the four phases of ‘‘interrupted feeding” (exploratory phase,
imbibing phase, probing phase and withdrawal phase). The
ontology also covers processes that are not directly ‘‘linked” to dis-
ease transmission and this, obviously, for reasons of completion.
Because of the principle of orthogonality, as was the case with
GAZ and MIRO, in all cases in which terms are already covered
by established public ontologies we adhere to these, along with
their descendants. For that, we search ontologies at the NCBO
Bioportal (http://bioportal.bioontology.org/) and directly import
relevant hits (IDs and deﬁnitions) into our ontologies. This is
notably the case for the Biological Processes sub-ontology of the
GO, as can be seen in Table 3 that lists a part containing metabolic
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ing terms in the GO, while for the remaining four, three have sim-
ilar (but obviously not identical) terms in the molecular function
sub-ontology of the GO. The decision to use terms (and their IDs)
verbatim from ontologies that have previously found their way into
the public domain is one that we strictly adhere to, as this provides
one of the most crucial advantages linked to the usage of ontolo-
gies, namely the possibility of cross-talk between databases that
share biological metadata. Initially we had decided against using
the parent term ID, as we often did not want to import the whole
tree associated to the terms. For example, in ChEBI, some insecti-
cides are listed as acaricides, while we consider them to be bona
ﬁde insecticides. In the meanwhile we have modiﬁed this standard
and decided, in most cases, to use the original IDs from OBO Foun-
dry ontologies such as GO and GAZ. This ‘‘transcription” is now in
progress and soon most such IDs will cease appearing as xrefs.
IDOMAL, is an ontology describing malaria; it is the ontology
that we are in the process of populating with terms and this is
the actual ontology that we decided to develop in the frame of
IDO, and which we plan to expand in the near future in order to
cover other vector-borne diseases as well. It is built based on
BFO and the IDO reference ontology (http://www.infectiousdis-
easeontology.org/IDO_ﬁles/IDO_10.08.07.obo.txt), and it is meant
to cover malaria on all possible levels. More than 1800 terms cur-
rently exist in IDOMAL, even though it cannot be considered as
complete. Table 4 shows semi-schematically, the contents of IDO-
MAL. These obviously include both the clinical aspects of the dis-
ease in the widest sense (i.e. including epidemiology, etc.) and
the biology of the disease that describes processes and objects of
no immediate clinical relevance. We consider as such items (e.g.
proteins) involved in the penetration of both mosquito and hu-
man/vertebrate cells as well as their interacting partners in the
Plasmodium parasites. Again, similarly to the case of the ontologyTable 4
Semi-schematic listing of the contents of IDOMAL. The hierarchy of terms listed here
does not correspond to what is to be found in IDOMAL, due to the BFO format
followed. Not all classes are listed.
Biology of disease
Malaria immunology
Malaria pathogens
Parasite–vector interactions
Parasite–vertebrate interactions
Clinical features
Malaria forms
Severe malaria
Cerebral malaria
Malaria in pregnancy
Malaria in children
Diagnostic procedures
Epidemiology
Disease control
Malaria eradication
Vector control
Treatment
Chemoprophylaxis
Chemotherapy
Immunization
Treatment of severe malaria
Parasite biology
Plasmodium cycle
Plasmodium species
Drug resistance
Vector biology
Anopheline species
Insecticide resistance
Mosquito immunology
Transmission-related physiology
Population biologyof physiological processes, we have taken care to include, wherever
possible, direct imports of pre-existing ontologies. This is again the
case with terms already described by the GO, but an additional
example is the Plasmodium parasite life cycle; all stages have
cross-references to the, at the moment, inactive Plasmodium life
cycle ontology.
We have now ﬁnished expanding the IDOMAL to cover the
immunology of malaria. This now covers the immune responses
and the immune state of the vertebrate hosts of the parasites
and in particular humans, and it is planned to also include, in the
future, the immune responses depicted by anopheline vectors
when they are ‘‘infected” with Plasmodium parasites during a blood
meal. While insect immunity’s possible interaction with pathogens
carried by the vector could be potentially used for intelligent
schemes aiming at halting pathogen transmission [30], the human
immune system could also be ‘‘recruited” in strategies aiming at
stopping malaria [31]: it should be stressed again that no vaccines
are available for malaria, and therefore any instrument that may be
of help in developing them is of utmost importance.
Since both IDO and IDOMAL are still in development, even if at
an advanced stage, our ontology may well have to be modiﬁed later
to take care of discrepancies between the two ontologies, given the
fact of their intimate relationship. Table 5 shows identical entities
in the IDO and IDOMAL, which obviously share the same deﬁnition
despite the fact that their names are slightly different; eventually,
IDOMAL will switch to IDO’s ID number, keeping the alternate
name, where necessary, as a synonym. In contrast, Table 6 lists ﬁve
examples of terms that, although very similar, have a clearly differ-
ent meaning in the two ontologies; the IDOMAL terms, here, have a
more speciﬁc meaning, thus at the end the terms will continue
appearing with different ID numbers in IDO and IDOMAL.3. Ontologies and vector-borne diseases: concluding remarks
The ontologies that we are constructing could be described, in a
sense, as pure application ontologies that are meant to form the
basis for speciﬁc tools such as speciﬁc databases or decision sup-
port systems for various diseases. The need for such tools became
apparent immediately after the ﬁrst working version of the MIRO
and its sibling IRbase were made public. Not only did the interna-
tional community, most prominently WHO-AFRO, immediately de-
cide to adopt both tools, but also already within a few months after
the initiation of data submission, there are about 1500 population
records in the database. This is about 1400 more samples than
what the previous insecticide resistance section in VectorBase car-
ried, the only repository for data of this kind. In addition to dat-
abases that are driven by ontologies in an increasing fashion (see
for example databases using the ontology-depending schema Cha-
do [32], such as FlyBase [33,34] and VectorBase [35,36]), ontologies
are ideal tools for the design and function of intelligent DSS. As a
matter of fact, we are aware of at least two such IT tools being
developed presently, the malaria decision support system MDSS
(http://www.ivcc.com/projects/mdss.htm) and the Dengue deci-
sion support system (http://www.ivcc.com/projects/ddss.htm),
that are driven in part, by ontologies developed or speciﬁcally
adapted for that purpose. In cases such as vector-borne diseases,
whose control is also hampered by weak infrastructure in endemic
countries, these DSS can be used by medical workers and health
agencies in remote areas, either for ongoing studies or, most cru-
cially, in cases that need immediate attention [37,38] such as
emerging epidemics.
One of the intricacies that we are already faced with is the
planned expansion of the malaria-oriented ontologies, to cover
many other vector-borne diseases. To understand the magnitude
of the challenge one should think of the fact, as stated earlier, that
Table 5
Terms in IDO with their counterparts in the draft IDOMAL.
IDO: term, ID IDOMAL: term, ID Common deﬁnition
Host role, 408 Host, 0000055 A role borne by an organism by virtue of the fact it provides an environment supportive for the survival or
reproduction of an entity of another type
Parasite role, 443 Parasite, 0000995 A symbiont role borne by an organism in virtue of the fact that it derives a growth, survival, or ﬁtness advantage
from symbiosis while the other symbiont’s growth, survival, or ﬁtness is reduced
Reservoir of infectious agent
role, 424
Reservoir, 0000058 A role borne by a material entity by virtue of the fact that it is a habitat in which an infectious agent is persisting
and multiplying and from which the infectious agent can be transmitted
Pathogen role, IDO:405 Pathogen, 0000063 A role borne by an object in virtue of the fact that it is sufﬁciently close to an organism towards which it has the
pathogenic disposition to allow processes resulting in disorder to occur
Infectious disease, 436 Infectious disease,
000001051
A disease whose physical basis is an infection
Virulence, 466 Virulence, 0000004 A quality that inheres in an infectious agent and is the degree to which realizations of the infectious disease
caused by the infectious agent become severe or fatal
Organism population, 509 Population,
0001254
An aggregate of organisms
Susceptibility, 467 Susceptibility
0001048
A quality that inheres in an entity and is the degree to which it can be harmed by another entity of a certain type
Immunization against
infectious agent, 497
Immunization,
0001039
A process by which an organism acquires immunity to an infectious agent
Table 6
Terms in IDO with their counterparts in the draft IDOMAL.
IDO: term, ID Deﬁnition IDOMAL: term,
ID
Deﬁnition
Infectious disease
prevalence, 485
A quality that inheres in an organism population and is the number of
realizations of an infectious disease of a certain type in the population at a
speciﬁed time
Prevalence of
malaria, 0000019
The number of malaria cases existing in a given
population at any given time
Infectious disease
incidence, 479
A quality that inheres in an organism population and is the number of
realizations of an infectious disease of a certain type for which the
infectious disease course begins during a speciﬁed period of time
Incidence of
malaria, 0001243
Prevalence over a stated time period
independent of whether the disease resulted
from a new infection or not
Infectious disease
epidemic, 502
A process in which there is a relatively signiﬁcant increase in the
infectious disease incidence of a certain type of infectious disease, relative
to the endemic level of realizations of that infectious disease, in an
organism population located in a geographically connected region
Epidemic
malaria, 0000116
Spread of malaria across a population beyond
what is characterized as endemic
Infectious disease
course, 495
A disease course that is the realization of an infectious disease Progression of
malaria, 0000091
All clinical features of malaria from infection to
cure or death
Herd immunity to
infectious
organism, 447
A collective resistance disposition that inheres in an infectious population
in virtue of the fact that a sufﬁcient number of members of the population
have immunity to an infectious agent
Herd immunity,
00000352
Resistance of a group to a pathogen due to
immunity of a large proportion of the group to
that pathogen
Acquired
immunity to
infectious
agent, 621
An immunity to infectious agent that inheres in an organism in virtue of
lymphocytes and lymphocyte receptors that came into being as a result of
a primary immune response
Acquired
immunity to
malaria, 0000543
Immunity to malaria gradually acquired by
infection
Vaccination
against
infectious
agent, 499
An active immunization process that begins with exposure of an organism
to a vaccine and results in immunity against an infectious agent
Malaria
vaccination,
0000021
The administration of antigenic material from
malaria pathogen to produce immunity to
malaria
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wide and ecologically diverse areas of the world, that they are
caused by completely different pathogens and that completely dif-
ferent species of vectors transmit them. Thus, the challenge now is
how to cover this broad spectrum of facts in a single ontology.
There is naturally the possibility of cutting through the Gordian
knot by devising separate ontologies for each disease. The coun-
ter-argument in this case would be that, brought to an extreme,
each pathogen-related malaria form (i.e. tertian, malignant and be-
nign, and quartan, which all have some distinct clinical features)
should have its own ontology, similar to the different forms of lym-
phatic ﬁlariasis, which are caused by different species of nema-
todes but whose clinical aspect differ only slightly. In addition,
similarities between these diseases and the agents that transmit
them may be obscured if different ontologies were used, and this
would certainly have a negative impact on their value in the long
term. Therefore, we are still trying to solve the knot in a non-Alex-
andrian way. By attempting to merge the ontologies in spe into one,
we can also actively support the rules of the OBO Foundry and pro-
vide an example of how the construction of a large and compre-
hensive ontology can, later on, provide advantages to its users.Acknowledgments
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